BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: McGowan EM, Haddadi N, Nassif NT, Lin Y. Targeting the SphK-S1P-SIPR Pathway as a Potential Therapeutic Approach for COVID-19. Int J Mol Sci 2020;21:E7189. [PMID: 33003377 DOI: 10.3390/ijms21197189] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
Number Citing Articles
1 Yuan Y, Jia G, Wu C, Wang W, Cheng L, Li Q, Li Z, Luo K, Yang S, Yan W, Su Z, Shao Z. Structures of signaling complexes of lipid receptors S1PR1 and S1PR5 reveal mechanisms of activation and drug recognition. Cell Res 2021. [PMID: 34526663 DOI: 10.1038/s41422-021-00566-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Cannavo A. G Protein-Coupled Receptor and Their Kinases in Cell Biology and Disease. IJMS 2022;23:5501. [DOI: 10.3390/ijms23105501] [Reference Citation Analysis]
3 Hutami IR, Izawa T, Khurel-Ochir T, Sakamaki T, Iwasa A, Tanaka E. Macrophage Motility in Wound Healing Is Regulated by HIF-1α via S1P Signaling. Int J Mol Sci 2021;22:8992. [PMID: 34445695 DOI: 10.3390/ijms22168992] [Reference Citation Analysis]
4 He Q, Bo J, Shen R, Li Y, Zhang Y, Zhang J, Yang J, Liu Y, Chiefari E. S1P Signaling Pathways in Pathogenesis of Type 2 Diabetes. Journal of Diabetes Research 2021;2021:1-12. [DOI: 10.1155/2021/1341750] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 García-Cárceles J, Caballero E, Gil C, Martínez A. Kinase Inhibitors as Underexplored Antiviral Agents. J Med Chem 2021. [PMID: 33970631 DOI: 10.1021/acs.jmedchem.1c00302] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Bai Y, Lockett AD, Gomes MT, Stearman RS, Machado RF. Sphingosine Kinase 1 Regulates the Pulmonary Vascular Immune Response. Cell Biochem Biophys 2021. [PMID: 34133010 DOI: 10.1007/s12013-021-01006-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Li W, Belwal T, Li L, Xu Y, Liu J, Zou L, Luo Z. Sphingolipids in foodstuff: Compositions, distribution, digestion, metabolism and health effects - A comprehensive review. Food Res Int 2021;147:110566. [PMID: 34399542 DOI: 10.1016/j.foodres.2021.110566] [Reference Citation Analysis]
8 Pan Y, Gao F, Zhao S, Han J, Chen F. Role of the SphK-S1P-S1PRs pathway in invasion of the nervous system by SARS-CoV-2 infection. Clin Exp Pharmacol Physiol 2021;48:637-50. [PMID: 33565127 DOI: 10.1111/1440-1681.13483] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Anand U, Jakhmola S, Indari O, Jha HC, Chen ZS, Tripathi V, Pérez de la Lastra JM. Potential Therapeutic Targets and Vaccine Development for SARS-CoV-2/COVID-19 Pandemic Management: A Review on the Recent Update. Front Immunol 2021;12:658519. [PMID: 34276652 DOI: 10.3389/fimmu.2021.658519] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Belopasov VV, Zhuravleva EN, Nugmanova NP, Abdrashitova AT. Post-covid-19 neurological syndromes. Journal of Clinical Practice 2021;12:69-82. [DOI: 10.17816/clinpract71137] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Schneider-Schaulies S, Schumacher F, Wigger D, Schöl M, Waghmare T, Schlegel J, Seibel J, Kleuser B. Sphingolipids: Effectors and Achilles Heals in Viral Infections? Cells 2021;10:2175. [PMID: 34571822 DOI: 10.3390/cells10092175] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Ziegler AC, Gräler MH. Barrier maintenance by S1P during inflammation and sepsis. Tissue Barriers 2021;:1940069. [PMID: 34152926 DOI: 10.1080/21688370.2021.1940069] [Reference Citation Analysis]
13 Beckmann N, Becker KA. Ceramide and Related Molecules in Viral Infections. Int J Mol Sci 2021;22:5676. [PMID: 34073578 DOI: 10.3390/ijms22115676] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
14 Törnquist K, Asghar MY, Srinivasan V, Korhonen L, Lindholm D. Sphingolipids as Modulators of SARS-CoV-2 Infection. Front Cell Dev Biol 2021;9:689854. [PMID: 34222257 DOI: 10.3389/fcell.2021.689854] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
15 Khan SA, Goliwas KF, Deshane JS. Sphingolipids in Lung Pathology in the Coronavirus Disease Era: A Review of Sphingolipid Involvement in the Pathogenesis of Lung Damage. Front Physiol 2021;12:760638. [PMID: 34690821 DOI: 10.3389/fphys.2021.760638] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Rowaiye AB, Okpalefe OA, Onuh Adejoke O, Ogidigo JO, Hannah Oladipo O, Ogu AC, Oli AN, Olofinase S, Onyekwere O, Rabiu Abubakar A, Jahan D, Islam S, Dutta S, Haque M. Attenuating the Effects of Novel COVID-19 (SARS-CoV-2) Infection-Induced Cytokine Storm and the Implications. J Inflamm Res 2021;14:1487-510. [PMID: 33889008 DOI: 10.2147/JIR.S301784] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
17 Gowda D, Ohno M, B Gowda SG, Chiba H, Shingai M, Kida H, Hui SP. Defining the kinetic effects of infection with influenza virus A/PR8/34 (H1N1) on sphingosine-1-phosphate signaling in mice by targeted LC/MS. Sci Rep 2021;11:20161. [PMID: 34635791 DOI: 10.1038/s41598-021-99765-0] [Reference Citation Analysis]